Novo Nordisk Stock Today (Nov 6, 2025): NVO steadies as White House GLP‑1 pricing deal lands; $10B Metsera bidding war heats up
Novo Nordisk ADRs closed at $47.36, down from a $47.75 open, after news of a White House deal to cut GLP-1 drug prices and expand Medicare/Medicaid access. The company confirmed lower U.S. prices and a pilot for Medicare Part D obesity drug coverage. Novo is also in a $10 billion bidding war with Pfizer for obesity-drug maker Metsera. Volume topped 29 million shares.